2026 NPPES data Otology & Neurotology Physician NPI 1649363334 D.O.
Verify on CMS →

MARK READER, D.O.

Otology & Neurotology Physician in PORTERVILLE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
583
Medicare Part D claims · 294 beneficiaries · Otology & Neurotology Physician avg: 401
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.8488/100
▼ 1 pts below national avg 83.1 · [object Object]
Industry payments
$128.91
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK READER, D.O. reported a CMS MIPS final score of 81.8488/100 — below the 83.1 national average — and filed 583 Medicare Part D claims in 2023.

81.8488/100
MIPS score · -1 vs avg
583
Part D claims, 2023
98%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK READER, D.O.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

82 36th percentile higher than 36% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK READER, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK READER, D.O.?

Near national average

NPI registry status

Active

Issued 10/02/2006

NPI 1649363334

Primary specialty

Otology & Neurotology Physician

Rare

333 US NPIs in this specialty

Medicare Part D claims

583 45% vs specialty avg

2023 prescription claims

Specialty avg: 401

MIPS final score

81.8488/100 1.2511999999999972% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Otology & Neurotology Physician compares to other specialties among California providers

California providers

Otology & Neurotology Physician share within California

1. Otology & Neurotology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otology & Neurotology Physician share within California

Medicare quality performance — MIPS

MARK READER, D.O.'s 2023 MIPS final score plotted against the Otology & Neurotology Physician national average

Near national average
MIPS Final Score
81.8488/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Otology & Neurotology Physician) — 81.8488/100 vs national avg 83.1

0%100%National avg83%81.8%
MIPS final score (Otology & Neurotology Physician) — 81.8488/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK READER, D.O. is a Otology & Neurotology Physician provider practicing in PORTERVILLE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.O.. NPI: 1649363334. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK READER, D.O. appears in the CMS NPPES registry as a Otology & Neurotology Physician provider holding D.O. credentials at 590 W PUTNAM AVE, PORTERVILLE, CA, 93257, with a listed phone of (559) 781-3700. NPI 1649363334 was issued on 10/02/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what READER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 583 prescription claims written by this provider, covering 294 Medicare beneficiaries and totaling roughly $16K in drug spend, split 2% brand-name and 98% generic by claim count, with an opioid prescribing rate of 8.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.8488/100 for the 2023 performance year (Quality 56.1858), compared with the national average of 83.1.

Otology & Neurotology Physician is a narrow specialty nationwide, with 333 enrolled providers across 46 states and an average of 401 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

590 W PUTNAM AVE
PORTERVILLE, CA 93257

Provider Details

NPI 1649363334
Specialty Otology & Neurotology Physician
Credentials D.O.
Gender Male
NPI Issued 10/02/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

81.8488
Final Score
Avg: 83.1
56.1858
Quality

Reporting: Individual

Hospital and facility affiliations

Facilities where MARK READER, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SEQUOIA FAMILY MEDICAL CENTER, INC.
PORTERVILLE, CA
SEQUOIA HEALTHCARE ALLIANCE
PORTERVILLE, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK READER, D.O.. Source: openpaymentsdata.cms.gov.

Total received

$129

Largest payer

Oticon Medical, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARK READER, D.O.. To verify MARK READER, D.O.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MARK READER, D.O. — brand share 2.0%
Specialty average (est.)

2% brand-name claims vs 98% generic, on 583 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

583
Total Claims
$16K
Total Drug Cost
294
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
804
Total Day Supply
18,439
Brand vs Generic
2% brand / 98% generic
Brand Drug Cost
$3K
Generic Drug Cost
$12K
Opioid Claims
48 (8.2% rate)
Antibiotic Claims
100

Patient Demographics

Average Patient Age
73.0 years
Avg HCC Risk Score
1.33
Gender Split
56% female / 44% male
Age Distribution
<65: 23, 65-74: 138, 75-84: 108, 85+: 25

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Fluticasone Propionate
137
Ipratropium Bromide
85
Azelastine Hcl
58
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
36
Cephalexin
34
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
33
Clotrimazole
32
Ofloxacin
29
Neomycin-Polymyxin-Hc
Neomycin/Polymyxin B/Hydrocort
17
Mometasone Furoate
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otology & Neurotology Physician Overview

How MARK READER, D.O. fits within the Otology & Neurotology Physician landscape nationally.

333
Otology & Neurotology Physician Providers in US
46
States with Otology & Neurotology Physician
401
Avg Claims per Provider

MARK READER, D.O.'s 583 claims are above the specialty average of 401.

Nearby Otology & Neurotology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as READER.

Compare Otology & Neurotology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK READER, D.O.'s specialty?
MARK READER, D.O. specializes in Otology & Neurotology Physician and practices in PORTERVILLE, California. Credentials: D.O..
How much does MARK READER, D.O. prescribe under Medicare Part D?
In 2023, MARK READER, D.O. wrote 583 Medicare Part D claims totaling $16K in drug costs for 294 beneficiaries.
What is MARK READER, D.O.'s Medicare quality score?
MARK READER, D.O. has a CMS MIPS Final Score of 81.8488/100 (Quality: 56.1858). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK READER, D.O. located?
MARK READER, D.O. is located at 590 W PUTNAM AVE, PORTERVILLE, CA, 93257. Phone: (559) 781-3700.
What is MARK READER, D.O.'s NPI number?
MARK READER, D.O.'s National Provider Identifier (NPI) is 1649363334, issued on 10/02/2006.
Does MARK READER, D.O. prescribe more brand-name or generic drugs?
MARK READER, D.O.'s prescribing is 2% brand-name and 98% generic drugs by claim count, with $3K in brand drug costs.
Does MARK READER, D.O. prescribe opioids?
Yes, MARK READER, D.O. had 48 opioid claims in 2023 with an opioid prescribing rate of 8.2%.
How many Otology & Neurotology Physician providers are there in the US?
There are 333 Otology & Neurotology Physician providers across 46 states in the US. The average Otology & Neurotology Physician provider writes 401 Medicare Part D claims per year.
What drugs does MARK READER, D.O. prescribe most often?
Based on 2023 Medicare Part D data, MARK READER, D.O.'s most frequently prescribed drugs include Fluticasone Propionate, Ipratropium Bromide, Azelastine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK READER, D.O. accept Medicare?
MARK READER, D.O. appears in CMS Medicare data with 583 Part D claims and 294 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK READER, D.O.'s credentials?
MARK READER, D.O.'s NPI is 1649363334 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology